Navigation Links
Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
Date:11/15/2013

ATLANTA, Nov. 15, 2013 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2). These findings, presented for the first time at Obesity Week 2013 on November 15, 2013, demonstrated significant weight loss and improvements in cardiometabolic risk markers in 147 obese individuals over 12 weeks of treatment, the largest and longest trial to date for the beloranib program.

"The latest results from this robust, larger scale trial represent the first full set of Phase 2 data for beloranib in severely obese patients," said Thomas Hughes, Ph.D., President and CEO of Zafgen.  "This patient population often remains beyond the reach of existing pharmacotherapy and there is a major unmet medical need for treatment of this serious disease.  We are very encouraged by the extent of weight loss observed in this trial and will continue to pursue beloranib as a pharmacological alternative to bariatric surgery."

Beloranib, a novel obesity therapy that utilizes a unique mechanism of action, is being studied for its ability to reduce body weight and improve cardiometabolic risk factors in obese patients.  The study presented was a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of a dose range of beloranib administered as twice-weekly subcutaneous injections for 12 weeks.  The trial enrolled 147 patients, of which 122 completed the study.  Subjects were mostly obese women with mean age 48.4 years, body weight (BW) 100.9  kg, and body mass index (BMI) 37.6 kg/m2, who were enrolled into one of the four arms of the trial (N=37 in 0.6 mg, 37 in 1.2 mg, 35 in 2.4 mg and 38 in placebo arm). Patients
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Encision Inc. (OTCQB:ECIA), a medical device company ... burns in minimally invasive surgery, today announced financial results ... 2014. The Company posted quarterly net revenue ... $414 thousand, or $(0.04) per share. These results compare ... loss of $50 thousand, or $(0.01) per share, in ...
(Date:10/31/2014)... , Oct. 30, 2014 Electronic ... electronic transmission of prescription related information between ... system allows a physician and nurse practitioner ... a medication error occurs during pharmacy operations. ... applications. It provides complete medical lists, conducts ...
(Date:10/30/2014)... , Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... company that designs, manufactures and markets innovative therapeutic ultrasonic ... announced today that it will report financial results for ... 6, 2014. The Company has scheduled a conference call ... pm ET to review the results. ...
Breaking Medicine Technology:Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2
... Resources, one of the world,s leading research and ... that, in 2008, human epidermal growth factor receptor ... Herceptin and GlaxoSmithKline/Nippon Kayaku,s Tykerb/Tyverb -- were the ... uptake of Herceptin and Tykerb/Tyverb and the expected ...
... -- Chindex International, Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent ... of China, today,announced results for the second quarter and first half ... Financial Highlights:, -- Revenue in the second ... a year over year basis;, ...
Cached Medicine Technology:Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11
(Date:10/31/2014)... 2014 Radiology and EMR Integration ... difference between diagnostic imaging centers but Connectivity is ... DigitalOne. “Differentiation is critical in all businesses ... you consider the intense competition and the downward ... will stand-out from the competition by fully integrating ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Carving pumpkins and ... send many children to emergency rooms in the United ... holidays, Halloween had the fifth highest number of ER ... to 2007-2013 data from the National Electronic Injury Surveillance ... involved the head, noted the American Academy of Orthopaedic ...
(Date:10/31/2014)... of Health will facilitate communication among scientists, clinicians, ... from diagnosis to treatment. The Research Domain Criteria ... Institute of Mental Health (NIMH), part of NIH, ... initiative. , The aim of the RDoC ... that translates basic science into clinical settings by ...
(Date:10/31/2014)... News) -- A comparison of two of the most ... gastric bypass helped patients shed more excess pounds than ... short-term complications and long-term hospitalizations. Gastric-bypass surgery makes ... your body does not absorb all the calories from ... Health. Gastric banding is a type of weight-loss procedure ...
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, 2014 (HealthDay ... of broken bones and injured joints, a new study reports. ... percent of people who had an eczema flare-up in the past ... percent had an injury that caused a limitation of function. ... had more than double the risk of having had a fracture ...
Breaking Medicine News(10 mins):Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2Health News:Halloween at the ER Is No Treat 2Health News:NIMH creates new unit to support its research domain criteria initiative 2Health News:Study Compares 2 Common Weight-Loss Surgeries 2Health News:Study Compares 2 Common Weight-Loss Surgeries 3Health News:Eczema Tied to Bone Fracture Risk in Study 2
... Jan. 13 (HealthDay News) -- Two extra steps may improve ... , A Pap smear is the standard test, but findings ... of the National Cancer Institute call for patients to ... after the Pap smear if they have HPV infections. , ...
... shows value of exercise in treating peripheral arterial disease , , ... that a planned program of walking is good for people ... should check the results of a new U.S. government-funded study. ... of whom didn,t have the pain that is the classic ...
... suggests , , TUESDAY, Jan. 13 (HealthDay News) -- Women calling ... to the hospital after an emergency medical services team had ... , It,s not clear why this was the case, but ... heart attacks. In particular, differences in initial symptoms could explain ...
... National Alliance for Caregiving Call on the New Congress ... CaregiversSAN MATEO, Calif., Jan. 13 There are more ... family members and loved ones: an aging or ailing ... spouse with Alzheimer,s, a sibling with a traumatic war ...
... from White,women on a range of worries about workplace, education and ... decade cited by greater,proportions of Black women than White women include: ... (84 % vs. 68 %), -- Unequal pay ... (72% vs. 57%), -- Limited opportunities for job ...
... S&R Communications Group has entered,a strategic partnership with ... for chorea associated with Huntington,s,disease (HD). Xenazine is ... any HD-related symptom. , ... to help Ovation launch,Xenazine," said S&R President Paul ...
Cached Medicine News:Health News:Walking Is Good for Blocked Leg Arteries 2Health News:Women With Heart Attack Symptoms See Delays in Care 2Health News:Women With Heart Attack Symptoms See Delays in Care 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 2Health News:Caregivers Need a Bailout Too! (or 1% for Families) 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 4Health News:Caregivers Need a Bailout Too! (or 1% for Families) 5Health News:Caregivers Need a Bailout Too! (or 1% for Families) 6Health News:YWCA Survey Shows Greater Economic Concerns Among Black Women Than White Women 2
... BchiVac V-500 with Vacuum Controller V-800 and water-cooled ... from Model V-500 is a ... most vacuum applications. Applications Ideally ... evaporators Laboratory vacuum source for instruments ...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... Electronic switching mechanism turns V-500 on and off as ... Model V-500 is a powerful PTFE membrane vacuum pump ... Ideally suited for use with up to two ...
... Combines BchiVac V-500 and water-cooled secondary condenser ... is a powerful PTFE membrane vacuum pump ... Applications Ideally suited for use ... Laboratory vacuum source for instruments including ...
... The Universal Vacuum System UVS400 is a ... The UVS400 combines a refrigerated vapor trap ... a single integrated unit. The easy-to-use, wide-mouth ... solvent into single jar for easy disposal. ...
Medicine Products: